Help patients find you. Join the Phothera Patient Directory. Sign Up
Slide

Phothera Scientific Advisory Board

ADVANCING PHOTOTHERAPY THROUGH CLINICAL EXPERTISE

Phothera’s Scientific Advisory Board brings together distinguished academic and clinical leaders who have made significant contributions to dermatology, inflammatory skin diseases, and phototherapy.

The 2026-2027 Phothera Scientific Advisory Board brings together leading dermatology experts to provide clinical and scientific perspectives on the evolving role of phototherapy in dermatologic care.

Meet Our 2026-2027 Scientific Advisory Board

Board-certified dermatologists recognized for their clinical leadership, research, and commitment to advancing patient care.

Board-Certified Dermatologist


Dr. Raja Sivamani is a board-certified integrative dermatologist, bioengineer, and Ayurvedic practitioner. He practices at Pacific Skin Institute and Zen Regen. He is the Director of Research at Integrative Skin Science and Research and the Integrative Research Institute and leads studies on pharmaceuticals, devices and phototherapy, nutrition, topical ingredients, epigenetics, microbiome, and longevity. He has over 200 peer-reviewed publications and serves as a lead editor for the educational platform LearnSkin, the Integrative Dermatology Symposium, and the Journal of Integrative Dermatology.

Board-Certified Dermatologist


Dr. Seemal R. Desai is a board-certified dermatologist and internationally recognized expert in pigmentary disorders. He is Founder and Medical Director of Innovative Dermatology in the Dallas-Fort Worth area and a Clinical Associate Professor of Dermatology at UT Southwestern Medical Center. His clinical and research interests include vitiligo, skin of color dermatology, psoriasis, and acne. He has authored hundreds of scientific publications, is a Past President of the American Academy of Dermatology, and serves as President of the Global Vitiligo Foundation.

Board-Certified Dermatologist


Dr. Nada Elbuluk is a board-certified dermatologist and Professor of Clinical Dermatology at the USC Keck School of Medicine, Department of Dermatology. She serves as the Founding Director of the USC Skin of Color and Pigmentary Disorders Program as well as the USC Dermatology Culture and Engagement Program. Dr. Elbuluk is a national and internationally recognized expert in skin of color, pigmentary disorders, and health equity. She is the immediate past president of the Skin of Color Society and a current board member of the Global Vitiligo Foundation.

Board-Certified Dermatologist


Dr. Pearl E. Grimes is an internationally recognized dermatologist and leading authority on vitiligo, melasma, and pigmentary disorders. She is Founder and Director of the Vitiligo & Pigmentation Institute of Southern California and Perl – The Melasma Research & Treatment Institute, and Director of The Grimes Center for Medical and Aesthetic Dermatology. She is a Clinical Professor of Dermatology at the David Geffen School of Medicine at UCLA, has authored more than 200 publications, and is the Immediate Past President of the Global Vitiligo Foundation.

Board-Certified Dermatologist


Dr. Iltefat Hamzavi is a board-certified dermatologist and co-director of the investigator-initiated research unit at Henry Ford Hospital, where his work focuses on pigmentary disorders, photomedicine, and hidradenitis suppurativa . He completed his dermatology residency at Wayne State University, followed by an advanced laser and photomedicine fellowship at the University of British Columbia He has served as founding Co-Chair of the Global Vitiligo Foundation and President of the Hidradenitis Suppurativa Foundation. He has co-authored over 300 peer-reviewed papers garnering more than 20,000 citations, ranking him in the top 0.5% of all physicians for academic productivity, and has been honored by the American Academy of Dermatology with the John Kenney Lifetime Achievement Award.

Board-Certified Dermatologist


Nicholas K. Mollanazar, MD, MBA, is an Associate Professor of Clinical Dermatology at the Perelman School of Medicine at the University of Pennsylvania and Vice Chair of Health Informatics and Access in the Department of Dermatology. He also serves as Co-Chair of Electronic Medical Record Governance at Penn Medicine. His clinical and research work focuses on chronic pruritus and inflammatory skin diseases, including prurigo nodularis, atopic dermatitis, and psoriasis. He is actively involved in clinical trials, resident education, and initiatives to improve patient access and the delivery of dermatologic care.

Board-Certified Dermatologist


E. James Song, MD, FAAD, is Director of Clinical Research and Chief Medical Officer at Frontier Dermatology and an Associate Professor at Washington State University. His clinical and research interests focus on immune-mediated and inflammatory skin diseases. He has served as principal investigator or lead principal investigator for over 50 clinical trials and authored numerous peer-reviewed publications. Dr. Song is a Councilor of the International Psoriasis Council, a member of the National Psoriasis Foundation Medical Advisory Board, and Senior Editor of the Journal of Psoriasis and Psoriatic Arthritis.

Explore the clinical evidence behind Phothera